The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on Hughes et al. Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). J. Clin. Med. 2022, 11 , 5158

Autor: Mistry, Pramod K.1 (AUTHOR) pramod.mistry@yale.edu, Kishnani, Priya S.2 (AUTHOR), Balwani, Manisha3 (AUTHOR), Charrow, Joel M.4 (AUTHOR), Hull, Judy5 (AUTHOR), Weinreb, Neal J.6 (AUTHOR), Cox, Timothy M.7 (AUTHOR)
Zdroj: Journal of Clinical Medicine. May2023, Vol. 12 Issue 9, p3269. 4p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje